Shilpa Biologicals partners with mAbTree Biologics AG for a novel immunooncology asset
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Experts urge early detection & better access to care
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Announces Rs. 317 crore investment in new recycling plant
Encourages working women to practice self-care
Subscribe To Our Newsletter & Stay Updated